UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Generic dispensing rates for substitutable drugs prescribed by general practitioners compared with other private ambulatory specialists: A study based on a French national reimbursement database

The European journal of general practice, 2024-12, Vol.30 (1), p.2407600

2024

Volltextzugriff (PDF)

Cost benefit analysis and the FDA: measuring the costs and benefits of drug approval under the PDUFA I-II, 1998–2005: By

Journal of regulatory economics, 2024-12, Vol.66 (2-3), p.174-180

DeCanio, Samuel

2024

Volltextzugriff (PDF)

Medicaid expansion and opioid prescriptions: Evidence from the Medical Expenditure Panel Survey

Health economics, 2024-11, Vol.33 (11), p.2439-2449

2024

Volltextzugriff (PDF)

Including the Household: Individual, Community and Household Factors Affecting Antiretroviral Therapy Adherence After ART Initiation in Cape Town, South Africa

AIDS and behavior, 2024-11, Vol.28 (11), p.3733-3747

2024

Volltextzugriff (PDF)

Politicians' proposals would only minimally lower US drug prices, says report; Advocates say multiple strategies must be used to lower prices as new drugs threaten to bankrupt health system

The Guardian (London), 2024-10-11

2024

Volltextzugriff (PDF)

Direct medical costs of cardiovascular diseases: Do cost components vary according to sex and age?

PloS one, 2024-10, Vol.19 (10), p.e0311599

2024

Volltextzugriff (PDF)

Lifetime healthcare expenditures across socioeconomic groups

BMC public health, 2024-10, Vol.24 (1), p.2751-16, Article 2751

2024

Volltextzugriff (PDF)

The prevalence of antiretroviral drug interactions with other drugs used in women living with HIV and its association with HIV drug change and patient compliance

BMC infectious diseases, 2024-10, Vol.24 (1), p.1123-11, Article 1123

2024

Volltextzugriff (PDF)

With Medicare's Annual Enrollment Period Days Away, Higher Costs and Benefit Changes Top Beneficiaries' Concerns

PR newswire, 2024-10-08

2024

Volltextzugriff (PDF)

Burden of disease and cost of illness of infants less than 6 months of age hospitalised with respiratory syncytial virus in Denmark - a 10-year national register-based study

BMC infectious diseases, 2024-10, Vol.24 (1), p.1098-9, Article 1098

2024

Volltextzugriff (PDF)

Low- And Middle-Income Countries Experienced Delays Accessing New Essential Medicines, 1982-2024

Health affairs (Millwood, Va.), 2024-10, Vol.43 (10), p.1410-6B

2024

Volltextzugriff (PDF)

Medicare drug price negotiations by the US Government

The lancet oncology, 2024-10, Vol.25 (10), p.1256-1256

Devi, Sharmila

2024

Volltextzugriff (PDF)

Postapproval Innovation For Oncology Drugs And The Inflation Reduction Act

Health affairs (Millwood, Va.), 2024-10, Vol.43 (10), p.1400-9B

2024

Volltextzugriff (PDF)

Descriptive Trends in Medicaid Antipsychotic Prescription Claims and Expenditures, 2016 – 2021

The Journal of Behavioral Health Services & Research, 2024-10, Vol.51 (4), p.516-528

2024

Volltextzugriff (PDF)

Health-related inequalities in out-of-pocket expenditure under universal health coverage in Taiwan: A cross-sectional decomposition analysis

Journal of health services research & policy, 2024-10, Vol.29 (4), p.240-247

2024

Volltextzugriff (PDF)

Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates

Health affairs (Millwood, Va.), 2024-10, Vol.43 (10), p.1420-12B

2024

Volltextzugriff (PDF)

Addressing gaps to strengthen patient-centricity in formulary decision-making: An example applied to Colorado's prescription drug affordability board implementation

Journal of managed care & specialty pharmacy, 2024-10, Vol.30 (10), p.1189-1190

2024

Volltextzugriff (PDF)

Patient Assistance Programs-A New Era of Law and Policy

JAMA : the journal of the American Medical Association, 2024-10, Vol.332 (13), p.1047

2024

Volltextzugriff (PDF)

Stockpiling at the Onset of the COVID-19 Pandemic: An Empirical Analysis of National Prescription Drug Sales and Prices

Management science, 2024-10, Vol.70 (10), p.6483-6501

2024

Volltextzugriff (PDF)

Response Aggregation to Obtain Truthful Answers to Sensitive Questions: Estimating the Prevalence of Illegal Purchases of Prescription Drugs

Journal of marketing research, 2024-10, Vol.61 (5), p.821-838

2024

Volltextzugriff (PDF)

Advocating green economy in India: The tug of war among income inequality, export diversification, and environmental quality

Sustainable development (Bradford, West Yorkshire, England), 2024-10, Vol.32 (5), p.4879-4894

2024

Volltextzugriff (PDF)

Opportunity and Equity Costs of Multilevel Adaptive Interventions to Reduce Opioid Prescribing

JAMA network open, 2024-10, Vol.7 (10), p.e2438335

Alderson, Sarah L

2024

Volltextzugriff (PDF)

Health Care Expenditure in United States Adults With Heart Failure With and Without Diabetes

The American journal of cardiology, 2024-10, Vol.228, p.10-15

2024

Volltextzugriff (PDF)

Evidence that intergenerational income mobility is the strongest predictor of drug overdose deaths in U. S. Midwest counties

The International journal of drug policy, 2024-10, Vol.132, p.104558, Article 104558

2024

Volltextzugriff (PDF)

Perception and knowledge of general practitioners on COPD management according to the GOLD23 document and reimbursement criteria for drugs prescription: an e-Delphi study

Current medical research and opinion, 2024-10, Vol.40 (10), p.1821-1826

2024

Volltextzugriff (PDF)

1 – 25 von 16.003

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11.249)
Mit Volltextzugriff
(11.068)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(11.151)
EZB Electronic Journals Library
(5.758)
Journals@Ovid Full Text
(5.075)
IngentaConnect Journals
(4.500)
NUS Single-Journal Subscriptions
(4.116)
EBSCOhost Business Source Ultimate
(2.643)
IngentaConnect Journals
(2.337)
JSTOR
(2.171)
Nexis Uni
(1.973)
Springer Nature - Complete Springer Journals
(1.839)
PAIS Index
(1.607)
Wiley Online Library Journals Frontfile Complete
(1.600)
Elsevier ScienceDirect Journals Complete
(1.456)
Applied Social Sciences Index & Abstracts (ASSIA)
(1.299)
Wiley Online Library Full Collection 2018
(1.138)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(850)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(749)
BMJ
(745)
Taylor & Francis Journals
(585)
SAGE Complete
(565)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Generic dispensing rates for substitutable drugs prescribed by general practitioners compared with other private ambulatory specialists: A study based on a French national reimbursement database

Cost benefit analysis and the FDA: measuring the costs and benefits of drug approval under the PDUFA I-II, 1998–2005: By

Medicaid expansion and opioid prescriptions: Evidence from the Medical Expenditure Panel Survey

Including the Household: Individual, Community and Household Factors Affecting Antiretroviral Therapy Adherence After ART Initiation in Cape Town, South Africa

Politicians' proposals would only minimally lower US drug prices, says report; Advocates say multiple strategies must be used to lower prices as new drugs threaten to bankrupt health system

Direct medical costs of cardiovascular diseases: Do cost components vary according to sex and age?

Lifetime healthcare expenditures across socioeconomic groups

The prevalence of antiretroviral drug interactions with other drugs used in women living with HIV and its association with HIV drug change and patient compliance

With Medicare's Annual Enrollment Period Days Away, Higher Costs and Benefit Changes Top Beneficiaries' Concerns

Burden of disease and cost of illness of infants less than 6 months of age hospitalised with respiratory syncytial virus in Denmark - a 10-year national register-based study

Low- And Middle-Income Countries Experienced Delays Accessing New Essential Medicines, 1982-2024

Medicare drug price negotiations by the US Government

Postapproval Innovation For Oncology Drugs And The Inflation Reduction Act

Descriptive Trends in Medicaid Antipsychotic Prescription Claims and Expenditures, 2016 – 2021

Health-related inequalities in out-of-pocket expenditure under universal health coverage in Taiwan: A cross-sectional decomposition analysis

Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates

Addressing gaps to strengthen patient-centricity in formulary decision-making: An example applied to Colorado's prescription drug affordability board implementation

Patient Assistance Programs-A New Era of Law and Policy

Stockpiling at the Onset of the COVID-19 Pandemic: An Empirical Analysis of National Prescription Drug Sales and Prices

Response Aggregation to Obtain Truthful Answers to Sensitive Questions: Estimating the Prevalence of Illegal Purchases of Prescription Drugs

Advocating green economy in India: The tug of war among income inequality, export diversification, and environmental quality

Opportunity and Equity Costs of Multilevel Adaptive Interventions to Reduce Opioid Prescribing

Health Care Expenditure in United States Adults With Heart Failure With and Without Diabetes

Evidence that intergenerational income mobility is the strongest predictor of drug overdose deaths in U. S. Midwest counties

Perception and knowledge of general practitioners on COPD management according to the GOLD23 document and reimbursement criteria for drugs prescription: an e-Delphi study

Suchergebnisse filtern